Antares, Lipocine expand testosterone therapy offerings with FDA nod for a new, oral med for hypogonadism
In 2018 with Xyosted, Antares brought to the market a user-friendly testosterone replacement therapy for hypogonadism, with the drug administered at home by weekly in...
Continue Reading →
